Berenberg Starts Emerson (EMR) at Sell
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- Twitter (TWTR) Tops Q3 EPS by 4c; Announces Restructuring, Workforce Reduction
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Berenberg initiates coverage on Emerson (NYSE: EMR) with a Sell rating and a price target of $41.00.
Analyst Simon Toennessen commented, "Following significant portfolio changes in recent months, we expect material downgrades to consensus (~20% for FY 2017 EPS) as the street moves to pro-forma numbers. In addition, a combination of: a) further cyclical pressure particularly from the oil and gas sector; b) lack of future transformative M&A; c) a more lacklustre dividend outlook; and d) FY 2017 valuation levels that sit more than 50% above the historical average (on pro-forma numbers) does not make us optimistic about Emerson shares."
Shares of Emerson closed at $54.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Securities Downgrades Community Health (CYH) to Underperform
- UPDATE: Stifel Downgrades Boston Properties Inc. (BXP) to Hold
- F5 Networks (FFIV) PT Raised to $120 at Jefferies
Create E-mail Alert Related CategoriesAnalyst Comments, Hot New Coverage, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!